OKLAHOMA CITY — Oklahoma Attorney General Gentner Drummond said he is exploring potential legal action against insulin manufacturers and pharmacy benefit managers for wrongful conduct that resulted in artificially increased prices for insulin.
Drummond has issued a Request for Proposal (RFP) for outside counsel to investigate conduct and potentially pursue litigation.
“I will not allow price-gouging and greed to put in harm’s way innocent Oklahomans who are dependent on insulin to survive,” Drummond said. “I will fight to hold accountable anyone who has hiked insulin prices illegally and prioritized profits over patients.”
Insulin, a hormone that helps convert food into energy, is critical to controlling blood sugar levels in patients with diabetes. Nearly 13 percent of Oklahoma adults are diagnosed with diabetes.
Want to reach a local audience and grow your business?
Our website is the perfect platform to connect with engaged readers in your local area.
Whether you're looking for banner ads, sponsored content, or custom promotions, we can tailor a package to meet your needs.
Contact us today to learn more about advertising opportunities!
CONTACT US NOW
